Statera Biopharma, Inc. (STAB)

USD 0.0

(0.0%)

Long Term Debt Summary of Statera Biopharma, Inc.

  • Statera Biopharma, Inc.'s latest annual long term debt in 2021 was 11.43 Million USD , up 16142.03% from previous year.
  • Statera Biopharma, Inc.'s latest quarterly long term debt in 2022 Q3 was 686.14 Thousand USD , down -13.51% from previous quarter.
  • Statera Biopharma, Inc. reported annual long term debt of 70.38 Thousand USD in 2020, down 0.0% from previous year.
  • Statera Biopharma, Inc. reported annual long term debt of - USD in 2019, down 0.0% from previous year.
  • Statera Biopharma, Inc. reported quarterly long term debt of 871.29 Thousand USD for 2022 Q1, down -92.38% from previous quarter.
  • Statera Biopharma, Inc. reported quarterly long term debt of 793.28 Thousand USD for 2022 Q2, down -8.95% from previous quarter.

Annual Long Term Debt Chart of Statera Biopharma, Inc. (2021 - 2006)

Historical Annual Long Term Debt of Statera Biopharma, Inc. (2021 - 2006)

Year Long Term Debt Long Term Debt Growth
2021 11.43 Million USD 16142.03%
2020 70.38 Thousand USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%
2015 - USD -100.0%
2014 7.32 Billion USD 2.79%
2013 7.12 Billion USD 7204.06%
2012 97.6 Million USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%

Peer Long Term Debt Comparison of Statera Biopharma, Inc.

Name Long Term Debt Long Term Debt Difference
America Great Health 1.12 Million USD -917.786%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. 1.29 Million USD -784.763%
Biora Therapeutics, Inc. 43.73 Million USD 73.863%
Bio-Path Holdings, Inc. 10 Thousand USD -114211.4%
Better Therapeutics, Inc. 10.34 Million USD -10.467%
Calithera Biosciences, Inc. 136 Thousand USD -8305.25%
Comera Life Sciences Holdings, Inc. 120.3 Thousand USD -9402.037%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. 8.69 Million USD -31.513%
Evelo Biosciences, Inc. 48.87 Million USD 76.613%
Evolutionary Genomics, Inc. 3.74 Million USD -205.34%
Finch Therapeutics Group, Inc. 28.4 Million USD 59.754%
Galera Therapeutics, Inc. 151.04 Million USD 92.432%
Innovation1 Biotech Inc. 218.99 Thousand USD -5119.722%
Kiromic BioPharma, Inc. 911.5 Thousand USD -1154.102%
Molecular Templates, Inc. 9.74 Million USD -17.339%
Navidea Biopharmaceuticals, Inc. 1.87 Million USD -510.731%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 19.06 Million USD 40.048%
Panbela Therapeutics, Inc. 4.19 Million USD -172.559%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 104.33 Million USD 89.044%
TRACON Pharmaceuticals, Inc. 732 Thousand USD -1461.631%
Trevena, Inc. 35.23 Million USD 67.556%
Vaxxinity, Inc. 13.26 Million USD 13.805%
Vaccinex, Inc. 26 Thousand USD -43865.923%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. - USD -Infinity%